Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases.
| Website | https://www.medsenic.com |
| Revenue | $1 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2010 |
| Address | 11, Rue de l'académie, Strasbourg, Grand Est 67000, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Research Services, Membership Organizations, Biotechnology, Organizations, Science and Engineering |
| Keywords | Biopharmaceutical, Autoimmune Diseases, Drug Development, Biotechnology, Pharmaceutical Research, Clinical Trials, New Drug Applications, Immunology, Innovative Therapies, Precision Medicine, Targeted Therapies, Medical Research, Healthcare, Pharmaceutical, Life Sciences, Drug Discovery, Biotechnology Research |
| Competitors | Novartis, Pfizer, Sanofi, Bayer, GSK, Bristol Myers Squibb, Amgen, Regeneron, Teva Pharmaceuticals, Lilly India +40 more (view full list) |
| SIC | SIC Code 86 Companies, SIC Code 861 Companies |
| NAICS | NAICS Code 813 Companies, NAICS Code 81 Companies, NAICS Code 813910 Companies, NAICS Code 81391 Companies, NAICS Code 8139 Companies |
Looking for a particular MEDSENIC employee's phone or email?
The MEDSENIC annual revenue was $1 million in 2026.
Francois Rieger is the Président of MEDSENIC.
2 people are employed at MEDSENIC.
MEDSENIC is based in Strasbourg, Grand Est.
The NAICS codes for MEDSENIC are [813, 81, 813910, 81391, 8139].
The SIC codes for MEDSENIC are [86, 861].